VXUS vs. PPH
VXUS (Vanguard Total International Stock ETF) and PPH (VanEck Pharmaceutical ETF) are both exchange-traded funds - VXUS is a Global Equities fund tracking the FTSE Global All Cap ex US Index, while PPH is a Health & Biotech Equities fund tracking the MVIS US Listed Pharmaceutical 25 Index. Both are passively managed. Over the past 10 years, VXUS returned 10.23%/yr vs 8.39%/yr for PPH. A 0.61 correlation means they provide meaningful diversification when combined. VXUS charges 0.05%/yr vs 0.36%/yr for PPH.
Performance
VXUS vs. PPH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, VXUS achieves a 15.42% return, which is significantly higher than PPH's 2.96% return. Over the past 10 years, VXUS has outperformed PPH with an annualized return of 10.23%, while PPH has yielded a comparatively lower 8.39% annualized return.
VXUS
- 1D
- 1.52%
- 1M
- 4.66%
- YTD
- 15.42%
- 6M
- 16.87%
- 1Y
- 32.10%
- 3Y*
- 18.53%
- 5Y*
- 8.83%
- 10Y*
- 10.23%
PPH
- 1D
- -1.04%
- 1M
- 4.48%
- YTD
- 2.96%
- 6M
- 3.80%
- 1Y
- 18.69%
- 3Y*
- 12.38%
- 5Y*
- 9.47%
- 10Y*
- 8.39%
VXUS vs. PPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
VXUS Vanguard Total International Stock ETF | 15.42% | 32.35% | 5.08% | 15.86% | -16.08% | 8.98% | 10.66% | 21.75% | -14.43% | 27.46% |
PPH VanEck Pharmaceutical ETF | 2.96% | 22.00% | 8.05% | 6.95% | 2.64% | 17.79% | 5.49% | 19.39% | -5.89% | 15.23% |
Correlation
The correlation between VXUS and PPH is 0.35, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.35 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.42 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.51 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.56 |
Correlation (All Time) Calculated using the full available price history since Jan 28, 2011 | 0.61 |
Over the past year, the correlation between VXUS and PPH has dropped to 0.35 - well below their long-term average of 0.61, suggesting their price drivers have been diverging.
VXUS vs. PPH - Sectors Allocation Comparison
Sectors
VXUS
PPH
Financial Services
-
Technology
-
Industrials
Consumer Cyclical
-
Basic Materials
-
Healthcare
Energy
-
Consumer Defensive
-
Communication Services
-
Utilities
-
Real Estate
-
Financial Services
VXUS
PPH
-
Technology
VXUS
PPH
-
Industrials
VXUS
PPH
Consumer Cyclical
VXUS
PPH
-
Basic Materials
VXUS
PPH
-
Healthcare
VXUS
PPH
Energy
VXUS
PPH
-
Consumer Defensive
VXUS
PPH
-
Communication Services
VXUS
PPH
-
Utilities
VXUS
PPH
-
Real Estate
VXUS
PPH
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
VXUS vs. PPH — Risk / Return Rank
VXUS
PPH
VXUS vs. PPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Vanguard Total International Stock ETF (VXUS) and VanEck Pharmaceutical ETF (PPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| VXUS | PPH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.94 | ||
| Sortino ratioReturn per unit of downside risk | +1.03 | ||
| Omega ratioGain probability vs. loss probability | 1.37 | 1.20 | +0.17 |
| Calmar ratioReturn relative to maximum drawdown | 2.86 | 1.74 | +1.12 |
| Martin ratioReturn relative to average drawdown | 11.00 | 4.30 | +6.70 |
Loading charts...
Drawdowns
VXUS vs. PPH - Drawdown Comparison
The maximum VXUS drawdown since its inception was -35.97%, smaller than the maximum PPH drawdown of -51.45%. Use the drawdown chart below to compare losses from any high point for VXUS and PPH.
Loading charts...
Drawdown Indicators
| VXUS | PPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -35.97% | -51.45% | +15.48% |
Max Drawdown (1Y)Largest decline over 1 year | -11.27% | -10.76% | -0.51% |
Max Drawdown (3Y)Largest decline over 3 years | -13.58% | -18.06% | +4.48% |
Max Drawdown (5Y)Largest decline over 5 years | -29.44% | -20.26% | -9.18% |
Max Drawdown (10Y)Largest decline over 10 years | -35.97% | -29.70% | -6.27% |
Current DrawdownCurrent decline from peak | 0.00% | -4.90% | +4.90% |
Average DrawdownAverage peak-to-trough decline | -8.20% | -17.29% | +9.09% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.93% | 4.45% | -1.52% |
Volatility
VXUS vs. PPH - Volatility Comparison
Vanguard Total International Stock ETF (VXUS) has a higher volatility of 6.87% compared to VanEck Pharmaceutical ETF (PPH) at 5.95%. This indicates that VXUS's price experiences larger fluctuations and is considered to be riskier than PPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| VXUS | PPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.87% | 5.95% | +0.92% |
Volatility (6M)Calculated over the trailing 6-month period | 14.09% | 12.18% | +1.91% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.11% | 17.66% | -1.55% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.23% | 15.14% | +1.09% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.21% | 17.00% | +0.21% |
VXUS vs. PPH - Expense Ratio Comparison
VXUS has a 0.05% expense ratio, which is lower than PPH's 0.36% expense ratio.
Dividends
VXUS vs. PPH - Dividend Comparison
VXUS's dividend yield for the trailing twelve months is around 2.63%, more than PPH's 2.05% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PPH VanEck Pharmaceutical ETF | 2.05% | 1.78% | 1.98% | 2.09% | 1.55% | 1.62% | 1.66% | 1.77% | 1.97% | 1.92% | 2.43% | 1.93% |
VXUS Vanguard Total International Stock ETF | 2.63% | 3.18% | 3.37% | 3.24% | 3.09% | 3.10% | 2.14% | 3.06% | 3.18% | 2.73% | 2.93% | 2.83% |
Frequently Asked Questions
VXUS and PPH have a correlation of 0.35, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
VXUS has higher volatility (6.87%) compared to PPH (5.95%). In terms of maximum drawdown, VXUS dropped -35.97% vs PPH's -51.45%.
On 10-year performance, VXUS leads with 10.23% vs 8.39% for PPH. On fees, VXUS is cheaper at 0.05% per year. On volatility, PPH has been the lower-risk option at 5.95%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, VXUS has performed better with a 10.23% return vs 8.39%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
VXUS is cheaper with a 0.05% expense ratio, compared with 0.36% for PPH.
VXUS has the higher dividend yield at 2.63%, compared with 2.05% for PPH.
VXUS is categorized as Global Equities, while PPH is Health & Biotech Equities. VXUS tracks FTSE Global All Cap ex US Index, while PPH tracks MVIS US Listed Pharmaceutical 25 Index. They also come from different issuers: Vanguard and VanEck. Their fees differ too: 0.05% for VXUS and 0.36% for PPH.
VXUS currently has the higher Sharpe Ratio (2.01 vs 1.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for VXUS and PPH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer